Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.90 USD
-0.38 (-8.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Price, Consensus and EPS Surprise
AQST 3.90 -0.38(-8.88%)
Will AQST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AQST based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AQST
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
Other News for AQST
OPI, RVNC and AQST are among after hour movers
Largest borrow rate increases among liquid names
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
Aquestive Therapeutics to Present Crossover Study Data for Libervantâ„¢ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Piper starts Aquestive at overweight, cites allergy reaction treatment